Over the last few years, royalty monetization deals have solidified their status as important financing alternatives for late-stage life sciences companies to consider in their fundraising initiatives ...

Forbes contributors publish independent expert analyses and insights. Dr. Robert Pearl covers the people, tech and business of healthcare. Generative AI is advancing faster than any technology in ...